Morning Commentary: New Insulet convertible trading up a point on swap

By Rebecca Melvin

New York, Sept. 8 – Insulet Corp.’s newly priced 1.25% convertibles due 2021 were trading well in the early going upon release for secondary dealings early Thursday and were up a point on swap, a syndicate source said.

The Bedford, Mass.-based medical device maker priced an upsized $300 million of the five-year senior notes at the rich, or tight, end of talked terms for a 1.25% to 1.75% coupon and a 27.5% to 32.5% initial conversion premium.

The new bonds were trading a bit above par with the paper’s underlying shares down fractionally.

“They are trading well,” said the syndicate source, noting that the trading price was fluid.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.